Literature DB >> 23975143

Thymosin β4 and tissue transglutaminase. Molecular characterization of cyclic thymosin β4.

Christine App1, Jana Knop, Thomas Huff, Heinrich Sticht, Ewald Hannappel.   

Abstract

Thymosin β4 is the prototype of β-thymosins and is present in almost every mammalian cell. It is regarded to be the main intracellular G-actin sequestering peptide. Thymosin β4 serves as a specific glutaminyl substrate for guinea pig transglutaminase. In the absence of an appropriate additional aminyl donor an ε-amino group of thymosin β4 serves also as an aminyl substrate and an intramolecular bond is formed concomitantly NH3 (17 Da) is lost. The molecular mass of the product is 4,949.6 Da. This is 16.3 Da less than the molecular mass of thymosin β4 (4,965.9 Da). Digestion with endopeptidases and Edman degradation of the fragments identified the exact position of the ring forming isopeptide bond. In spite of 3 glutaminyl and 9 lysyl residues of thymosin β4 only one isopeptide bond between Lys16 and Gln36 was formed (cyclic thymosin β4). These two amino acid residues are conserved in all β-thymosins. Cyclic thymosin β4 still forms a complex with G-actin albeit the stability of the complex is about one fiftieth of the stability of the thymosin β4 × G-actin complex.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975143     DOI: 10.1007/s10930-013-9507-0

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  54 in total

1.  TetraThymosinbeta is required for actin dynamics in Caenorhabditis elegans and acts via functionally different actin-binding repeats.

Authors:  Marleen Van Troys; Kanako Ono; Daisy Dewitte; Veronique Jonckheere; Natalie De Ruyck; Joël Vandekerckhove; Shoichiro Ono; Christophe Ampe
Journal:  Mol Biol Cell       Date:  2004-07-21       Impact factor: 4.138

Review 2.  Identification of interaction partners of β-thymosins: application of thymosin β4 labeled by transglutaminase.

Authors:  Christine App; Jana Knop; Hans Georg Mannherz; Ewald Hannappel
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

3.  Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells.

Authors:  K M Malinda; A L Goldstein; H K Kleinman
Journal:  FASEB J       Date:  1997-05       Impact factor: 5.191

4.  Methods to measure actin polymerization.

Authors:  J A Cooper; T D Pollard
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Thymosin beta4 accelerates wound healing.

Authors:  K M Malinda; G S Sidhu; H Mani; K Banaudha; R K Maheshwari; A L Goldstein; H K Kleinman
Journal:  J Invest Dermatol       Date:  1999-09       Impact factor: 8.551

6.  Ciboulot regulates actin assembly during Drosophila brain metamorphosis.

Authors:  I Boquet; R Boujemaa; M F Carlier; T Préat
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

Review 7.  The beta-thymosins: intracellular and extracellular activities of a versatile actin binding protein family.

Authors:  Hans Georg Mannherz; Ewald Hannappel
Journal:  Cell Motil Cytoskeleton       Date:  2009-10

8.  Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection.

Authors:  Rabea Hinkel; Chiraz El-Aouni; Tonia Olson; Jan Horstkotte; Stefan Mayer; Sebastian Müller; Michael Willhauck; Christine Spitzweg; Franz-Josef Gildehaus; Wolfgang Münzing; Ewald Hannappel; Ildiko Bock-Marquette; J Michael DiMaio; Antonis K Hatzopoulos; Peter Boekstegers; Christian Kupatt
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

9.  Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable.

Authors:  D Safer; M Elzinga; V T Nachmias
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

10.  Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.

Authors:  Nicola Smart; Catherine A Risebro; Athalie A D Melville; Kelvin Moses; Robert J Schwartz; Kenneth R Chien; Paul R Riley
Journal:  Nature       Date:  2006-11-15       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.